Research > ETFs > ETF / ETP Commentary > 

REX Drone ETF DRNZ Glides Past $100 Million AUM Goalpost

The REX Drone ETF (DRNZ) may only have been on the market for less than a year now, but this fund has certainly enjoyed fortuitous momentum in the past few months. Recently, the fund passed the laudable $100 million threshold for assets under management. Currently, as of June 2, 2026, DRNZ has $119 million in assets under management. Key Takeaways:The REX Drone ETF (DRNZ) is sitting well over the $100 AUM threshold, as of June 2, 2026. Part of the fund’s success may be attributed to its index’s stock selection process, as some of the index’s individual stocks had incredibly strong performances in May. Beyond individual companies, DRNZ is also benefitting from favorable defense and AI trends that favor the drone and unmanned aerial vehicle (UAV) space. As one would expect from the fund’s title, DRNZ provides focused exposure to companies across the globe that are engaged in the drone and unmanned aerial vehicle (UAV) business. Notably, this includes for both defense and commercial use.  See More: 3 Stocks Drive Strong Performance Inside DRNZ This fund saw significant inflows this year, which helped propel it past the $100 million goal post. Between January 1, 2026 and May 29, 2026, DRNZ received about $71 million in net inflows.   DRNZ builds its global exposure to these industries with the help of the VettaFi Drone Index. By examining how the index’s constituents performed in May, advisors and investors can better understand the growing enthusiasm behind the fund’s approach. The Drone Stocks that Soared in MayIn particular, many of the companies within the index’s tech sector saw breakout performances in May. For example, Unusual Machines Inc. saw returns rise a whopping 123% for the month, driven in part by a Wall Street Journal report that the Trump administration may choose the company for a Pentagon funding deal.  Meanwhile, Ondas Inc. also had a terrific May, with returns of 29.12% for the month. To make matters even better for the company looking ahead, Ondas just announced a new multimillion deal with the U.S. Navy to provide high-altitude balloons.  See More: Drone Funding News Sent DRNZ 15% Higher While the strength of these individual companies is already an attractive factor for the fund, there are also broad factors working in favor of the drone industry. While geopolitical tensions are escalating, the U.S. government is making a thorough effort to amplify its defense spending, with the administration already proposing a defense budget of $1.5 trillion for Fiscal Year 2027.  Defense spending isn’t the only factor working in favor of the drone and UAV industry right now. Momentum from AI innovation and adoption won’t be going away any time soon, and drone and UAV companies of all kinds could certainly stand to benefit.  All in all, this approach has led to DRNZ offering a highly potent performance thus far this year. Year to date, the fund is up 32.18%, as of June 2, 2026. For more news, information, and analysis, visit the Thematic Investing Content Hub. VettaFi LLC (“VettaFi”) is the index provider for DRNZ which it receives an index licensing fee. However, DRNZ is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of DRNZ.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.